• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Hair Removal Duet

Article

San Francisco -- Topical eflornithine hydrochloride 13.9 percent cream (Vaniqa) can be used safely by patients undergoing laser hair removal and may have added value for improving the response to photoepilation, especially early on, according to results of a double-blinded study presented by Stacy R. Smith, M.D., at the annual meeting of the American Academy of Dermatology.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.